Focused on large-scale proteome analysis, the company is developing a single‑molecule platform designed to measure and quantify billions of proteins in a single experiment. Its technology aims to expand researchers’ ability to study the proteome, an area viewed as the next frontier after genomics. I...
No congressional trades have been disclosed for Nautilus Biotechnology Inc (NAUT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.